Point72 Asia (Singapore) Pte. Ltd. Ikena Oncology, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 22,146 shares of IKNA stock, worth $35,433. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,146
Previous 45,520
51.35%
Holding current value
$35,433
Previous $75.1 Million
48.99%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding IKNA
# of Institutions
61Shares Held
30.6MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$8.03 Million1.07% of portfolio
-
Bvf Inc San Francisco, CA4.77MShares$7.63 Million0.26% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$6.55 Million2.33% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.66 Million0.14% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.6 Million5.77% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $58M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...